Last reviewed · How we verify
Deep nasopharyngeal swab
Deep nasopharyngeal swab is a Biologic drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 2 development for Detection of respiratory pathogens (e.g., SARS-CoV-2, influenza, other viruses).
A deep nasopharyngeal swab is a diagnostic sampling procedure that collects respiratory secretions from the nasopharynx for laboratory analysis.
A deep nasopharyngeal swab is a diagnostic sampling procedure that collects respiratory secretions from the nasopharynx for laboratory analysis. Used for Detection of respiratory pathogens (e.g., SARS-CoV-2, influenza, other viruses).
At a glance
| Generic name | Deep nasopharyngeal swab |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Therapeutic area | Diagnostics |
| Phase | Phase 2 |
Mechanism of action
This is a clinical diagnostic tool rather than a pharmaceutical drug. The swab collects samples from deep within the nasopharynx (the upper part of the pharynx behind the nose) for detection of pathogens, typically viruses such as SARS-CoV-2, influenza, or other respiratory pathogens. The collected sample is then analyzed using molecular or antigen-based testing methods.
Approved indications
- Detection of respiratory pathogens (e.g., SARS-CoV-2, influenza, other viruses)
Common side effects
- Mild discomfort or gagging
- Epistaxis (nosebleed)
- Nasal irritation
Key clinical trials
- Minimal Flow Anesthesia and Infection Risk (NA)
- Transnasal Versus Suprazygomatic SPG Block in Persistant Idiopathic Facial Pain
- Impact of Bacterial Expression and Immune Response in the Severity of Pertussis (NA)
- Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. (NA)
- Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic
- LIPId Profile Changes in Inflammatory Conditions Induced by SARS-CORoronavirus-2
- Block of the Sphenopalatine Nerve Ganglion for Postoperative Analgesia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Deep nasopharyngeal swab CI brief — competitive landscape report
- Deep nasopharyngeal swab updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about Deep nasopharyngeal swab
What is Deep nasopharyngeal swab?
How does Deep nasopharyngeal swab work?
What is Deep nasopharyngeal swab used for?
Who makes Deep nasopharyngeal swab?
What development phase is Deep nasopharyngeal swab in?
What are the side effects of Deep nasopharyngeal swab?
Related
- Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
- Therapeutic area: All drugs in Diagnostics
- Indication: Drugs for Detection of respiratory pathogens (e.g., SARS-CoV-2, influenza, other viruses)
- Compare: Deep nasopharyngeal swab vs similar drugs
- Pricing: Deep nasopharyngeal swab cost, discount & access